← Back to Search

Cardiac Monitor

Blood Volume Monitoring for Blood Loss

N/A
Waitlist Available
Research Sponsored by Zynex Monitoring Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up length of pacu stay (range: 46 to 353 minutes)
Awards & highlights
No Placebo-Only Group

Summary

The primary objective is to evaluate the the changes in the Relative Index in post abdominal or pelvic surgery patients on the Cardiac Monitor Model CM-1500.

Eligible Conditions
  • Blood Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~length of pacu stay (range: 46 to 353 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and length of pacu stay (range: 46 to 353 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Relative Index Change During PACU Stay

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Blood Volume MonitoringExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CM-1500
2021
Completed Phase 1
~230

Find a Location

Who is running the clinical trial?

Zynex Monitoring SolutionsLead Sponsor
8 Previous Clinical Trials
661 Total Patients Enrolled
Wake Forest University Health SciencesOTHER
1,361 Previous Clinical Trials
1,039,809 Total Patients Enrolled
~42 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top